分析持续接受肾脏替代治疗的患者 30 天重症监护死亡率的代谢变化预测因素。

IF 2.9 Q3 NUTRITION & DIETETICS
Vaidas Vicka , Alvita Vickiene , Sigute Miskinyte , Ieva Bartuseviciene , Ingrida Lisauskiene , Mindaugas Serpytis , Donata Ringaitiene , Jurate Sipylaite
{"title":"分析持续接受肾脏替代治疗的患者 30 天重症监护死亡率的代谢变化预测因素。","authors":"Vaidas Vicka ,&nbsp;Alvita Vickiene ,&nbsp;Sigute Miskinyte ,&nbsp;Ieva Bartuseviciene ,&nbsp;Ingrida Lisauskiene ,&nbsp;Mindaugas Serpytis ,&nbsp;Donata Ringaitiene ,&nbsp;Jurate Sipylaite","doi":"10.1016/j.clnesp.2024.08.021","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Acute kidney injury patients on continuous renal replacement therapy are subjected to alterations in metabolism, which in turn are associated with worse clinical outcome and mortality. The aim of this study is to determine which metabolism indicators can be used as independent predictors of 30 days intensive care unit (ICU) mortality.</p></div><div><h3>Methods</h3><p>This was a prospective observational study on critical care patients on renal replacement therapy. Integrated approach of metabolism evaluation was used, combining the energy expenditure measured by indirect calorimetry, bioelectrical impedance provided fat free mass index (FFMI), amino acid and glucose concentrations. ICU mortality was defined as all cause 30 days mortality. Regression analysis was conducted to determine the conventional and metabolism associated predictors of mortality.</p></div><div><h3>Results</h3><p>The study was conducted between the 2021 March and 2022 October. 60 high mortality risk patients (APACHE II of 22.98 ± 7.87, 97% on vasopressors, 100% on mechanical ventilation) were included during the period of the study. The rate of 30 days ICU mortality was 50% (n = 30). Differences across survivors and non-survivors in metabolic predictors were noted in energy expenditure (kcal/kg/day) (19.79 ± 5.55 vs 10.04 ± 3.97 p = 0.013), amino acid concentrations (mmol/L) (2.40 ± 1.06 vs 1.87 ± 0.90 p = 0.040) and glucose concentrations (mmol/L) (7.89 ± 1.90 vs 10.04 ± 3.97 p = 0.010). No differences were noted in FFMI (23.38 ± 4.25 vs 21.95 ± 3.08 p = 0.158). In the final linear regression analysis model, lower energy expenditure (exp(B) = 0.852 CI95%: 0.741–0.979 p = 0.024) and higher glucose (exp(B) = 1.360 CI95%: 1.013–1.824 p = 0.041) remained as independent predictors of the higher mortality.</p></div><div><h3>Conclusion</h3><p>The results of the study imply strong association between the metabolic alterations and ICU outcome. Our findings suggest that lower systemic amino acid concentration, lower energy expenditure and higher systemic glucose concentration are predictive of 30 days ICU mortality.</p></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"63 ","pages":"Pages 944-951"},"PeriodicalIF":2.9000,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2405457724012920/pdfft?md5=6089a4c8e9c3cbe2e839a57e8b5d9b20&pid=1-s2.0-S2405457724012920-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Analysis of metabolic alterations as 30 days intensive care mortality predictors for patients undergoing continuous renal replacement therapy\",\"authors\":\"Vaidas Vicka ,&nbsp;Alvita Vickiene ,&nbsp;Sigute Miskinyte ,&nbsp;Ieva Bartuseviciene ,&nbsp;Ingrida Lisauskiene ,&nbsp;Mindaugas Serpytis ,&nbsp;Donata Ringaitiene ,&nbsp;Jurate Sipylaite\",\"doi\":\"10.1016/j.clnesp.2024.08.021\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Acute kidney injury patients on continuous renal replacement therapy are subjected to alterations in metabolism, which in turn are associated with worse clinical outcome and mortality. The aim of this study is to determine which metabolism indicators can be used as independent predictors of 30 days intensive care unit (ICU) mortality.</p></div><div><h3>Methods</h3><p>This was a prospective observational study on critical care patients on renal replacement therapy. Integrated approach of metabolism evaluation was used, combining the energy expenditure measured by indirect calorimetry, bioelectrical impedance provided fat free mass index (FFMI), amino acid and glucose concentrations. ICU mortality was defined as all cause 30 days mortality. Regression analysis was conducted to determine the conventional and metabolism associated predictors of mortality.</p></div><div><h3>Results</h3><p>The study was conducted between the 2021 March and 2022 October. 60 high mortality risk patients (APACHE II of 22.98 ± 7.87, 97% on vasopressors, 100% on mechanical ventilation) were included during the period of the study. The rate of 30 days ICU mortality was 50% (n = 30). Differences across survivors and non-survivors in metabolic predictors were noted in energy expenditure (kcal/kg/day) (19.79 ± 5.55 vs 10.04 ± 3.97 p = 0.013), amino acid concentrations (mmol/L) (2.40 ± 1.06 vs 1.87 ± 0.90 p = 0.040) and glucose concentrations (mmol/L) (7.89 ± 1.90 vs 10.04 ± 3.97 p = 0.010). No differences were noted in FFMI (23.38 ± 4.25 vs 21.95 ± 3.08 p = 0.158). In the final linear regression analysis model, lower energy expenditure (exp(B) = 0.852 CI95%: 0.741–0.979 p = 0.024) and higher glucose (exp(B) = 1.360 CI95%: 1.013–1.824 p = 0.041) remained as independent predictors of the higher mortality.</p></div><div><h3>Conclusion</h3><p>The results of the study imply strong association between the metabolic alterations and ICU outcome. Our findings suggest that lower systemic amino acid concentration, lower energy expenditure and higher systemic glucose concentration are predictive of 30 days ICU mortality.</p></div>\",\"PeriodicalId\":10352,\"journal\":{\"name\":\"Clinical nutrition ESPEN\",\"volume\":\"63 \",\"pages\":\"Pages 944-951\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2024-08-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2405457724012920/pdfft?md5=6089a4c8e9c3cbe2e839a57e8b5d9b20&pid=1-s2.0-S2405457724012920-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical nutrition ESPEN\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2405457724012920\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"NUTRITION & DIETETICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical nutrition ESPEN","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405457724012920","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}
引用次数: 0

摘要

背景:接受持续肾脏替代治疗的急性肾损伤患者的新陈代谢会发生改变,而这反过来又会导致临床预后和死亡率的恶化。本研究旨在确定哪些代谢指标可作为重症监护病房(ICU)30 天死亡率的独立预测指标:这是一项针对接受肾脏替代治疗的重症监护患者的前瞻性观察研究。采用综合代谢评估方法,结合间接热量计测量的能量消耗、生物电阻抗提供的无脂肪质量指数(FFMI)、氨基酸和葡萄糖浓度。重症监护室死亡率定义为所有原因导致的 30 天死亡率。研究人员进行了回归分析,以确定死亡率的常规预测因素和代谢相关预测因素:研究在 2021 年 3 月至 2022 年 10 月期间进行。研究期间纳入了 60 名高死亡率风险患者(APACHE II 为 22.98±7.87,97% 使用血管加压药,100% 使用机械通气)。重症监护室 30 天死亡率为 50%(30 人)。幸存者和非幸存者的代谢预测指标在能量消耗(千卡/千克/天)(19.79 ±5.55 vs 10.04 ±3.97 p=0.013)、氨基酸浓度(毫摩尔/升)(2.40 ±1.06 vs 1.87 ±0.90 p=0.040)和葡萄糖浓度(毫摩尔/升)(7.89 ±1.90 vs 10.04 ±3.97 p=0.010)方面存在差异。FFMI(23.38 ±4.25 vs 21.95 ±3.08 p=0.158)无差异。在最终的线性回归分析模型中,能量消耗较低(exp(B)= 0.852 CI95%:0.741-0.979 p=0.024)和较高的葡萄糖(exp(B)=1.360 CI95%:结论:研究结果表明,新陈代谢改变与重症监护室的预后密切相关。我们的研究结果表明,较低的全身氨基酸浓度、较低的能量消耗和较高的全身葡萄糖浓度可预测 30 天 ICU 死亡率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Analysis of metabolic alterations as 30 days intensive care mortality predictors for patients undergoing continuous renal replacement therapy

Background

Acute kidney injury patients on continuous renal replacement therapy are subjected to alterations in metabolism, which in turn are associated with worse clinical outcome and mortality. The aim of this study is to determine which metabolism indicators can be used as independent predictors of 30 days intensive care unit (ICU) mortality.

Methods

This was a prospective observational study on critical care patients on renal replacement therapy. Integrated approach of metabolism evaluation was used, combining the energy expenditure measured by indirect calorimetry, bioelectrical impedance provided fat free mass index (FFMI), amino acid and glucose concentrations. ICU mortality was defined as all cause 30 days mortality. Regression analysis was conducted to determine the conventional and metabolism associated predictors of mortality.

Results

The study was conducted between the 2021 March and 2022 October. 60 high mortality risk patients (APACHE II of 22.98 ± 7.87, 97% on vasopressors, 100% on mechanical ventilation) were included during the period of the study. The rate of 30 days ICU mortality was 50% (n = 30). Differences across survivors and non-survivors in metabolic predictors were noted in energy expenditure (kcal/kg/day) (19.79 ± 5.55 vs 10.04 ± 3.97 p = 0.013), amino acid concentrations (mmol/L) (2.40 ± 1.06 vs 1.87 ± 0.90 p = 0.040) and glucose concentrations (mmol/L) (7.89 ± 1.90 vs 10.04 ± 3.97 p = 0.010). No differences were noted in FFMI (23.38 ± 4.25 vs 21.95 ± 3.08 p = 0.158). In the final linear regression analysis model, lower energy expenditure (exp(B) = 0.852 CI95%: 0.741–0.979 p = 0.024) and higher glucose (exp(B) = 1.360 CI95%: 1.013–1.824 p = 0.041) remained as independent predictors of the higher mortality.

Conclusion

The results of the study imply strong association between the metabolic alterations and ICU outcome. Our findings suggest that lower systemic amino acid concentration, lower energy expenditure and higher systemic glucose concentration are predictive of 30 days ICU mortality.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinical nutrition ESPEN
Clinical nutrition ESPEN NUTRITION & DIETETICS-
CiteScore
4.90
自引率
3.30%
发文量
512
期刊介绍: Clinical Nutrition ESPEN is an electronic-only journal and is an official publication of the European Society for Clinical Nutrition and Metabolism (ESPEN). Nutrition and nutritional care have gained wide clinical and scientific interest during the past decades. The increasing knowledge of metabolic disturbances and nutritional assessment in chronic and acute diseases has stimulated rapid advances in design, development and clinical application of nutritional support. The aims of ESPEN are to encourage the rapid diffusion of knowledge and its application in the field of clinical nutrition and metabolism. Published bimonthly, Clinical Nutrition ESPEN focuses on publishing articles on the relationship between nutrition and disease in the setting of basic science and clinical practice. Clinical Nutrition ESPEN is available to all members of ESPEN and to all subscribers of Clinical Nutrition.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信